The average one-year price target for Core Scientific, Inc. - Equity Right (OTCPK:CORZR) has been revised to $0.07 / share. This is an increase of 12.87% from the prior estimate of $0.06 dated October 29, 2025.
The price target is an average of many targets provided by analysts. The latest targets range from a low of $0.05 to a high of $0.11 / share. The average price target represents a decrease of 77.37% from the latest reported closing price of $0.32 / share.
What is the Fund Sentiment?
There are 1 funds or institutions reporting positions in Core Scientific, Inc. - Equity Right. This is unchanged over the last quarter. Average portfolio weight of all funds dedicated to CORZR is 0.00%, an increase of 86.80%. Total shares owned by institutions decreased in the last three months by 33.67% to 328K shares.
What are Other Shareholders Doing?
BlackRock Credit Strategies Fund holds 328K shares. In its prior filing, the firm reported owning 495K shares , representing a decrease of 50.76%. The firm decreased its portfolio allocation in CORZR by 86.80% over the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
